BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12920041)

  • 1. Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia.
    Holleman A; den Boer ML; Kazemier KM; Janka-Schaub GE; Pieters R
    Blood; 2003 Dec; 102(13):4541-6. PubMed ID: 12920041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased PARP and procaspase-2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemia.
    Holleman A; den Boer ML; Kazemier KM; Beverloo HB; von Bergh AR; Janka-Schaub GE; Pieters R
    Blood; 2005 Sep; 106(5):1817-23. PubMed ID: 15899912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological characteristics and prognostic value of in vitro three-drug resistance to prednisolone, L-asparaginase, and vincristine in childhood acute lymphoblastic leukemia.
    Hongo T; Yamada S; Yajima S; Watanabe C; Fujii Y; Kawasaki H; Yazaki M; Hanada R; Horikoshi Y
    Int J Hematol; 1999 Dec; 70(4):268-77. PubMed ID: 10643153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia.
    Kaspers GJ; Veerman AJ; Pieters R; Van Zantwijk CH; Smets LA; Van Wering ER; Van Der Does-Van Den Berg A
    Blood; 1997 Oct; 90(7):2723-9. PubMed ID: 9326239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of prognostic value of in vitro drug resistance and bone marrow residual disease on day 15 of therapy in childhood acute lymphoblastic leukemia.
    Styczynski J; Piatkowska M; Jaworska-Posadzy A; Czyzewski K; Kubicka M; Kolodziej B; Kurylo-Rafinska B; Debski R; Pogorzala M; Wysocki M
    Anticancer Res; 2012 Dec; 32(12):5495-9. PubMed ID: 23225457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Insulin-mediated Regulation of AKT Signaling in Childhood Acute Lymphoblastic Leukemia.
    Wang J; Xue HM; Chen YR; Xu HG; Lin SF; Tang XK; Chen C
    J Pediatr Hematol Oncol; 2019 Mar; 41(2):96-104. PubMed ID: 30688831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo.
    Kang MH; Kang YH; Szymanska B; Wilczynska-Kalak U; Sheard MA; Harned TM; Lock RB; Reynolds CP
    Blood; 2007 Sep; 110(6):2057-66. PubMed ID: 17536015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia.
    Pieters R; Huismans DR; Loonen AH; Hählen K; van der Does-van den Berg A; van Wering ER; Veerman AJ
    Lancet; 1991 Aug; 338(8764):399-403. PubMed ID: 1678081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia.
    Styczynski J; Pieters R; Huismans DR; Schuurhuis GJ; Wysocki M; Veerman AJ
    Br J Haematol; 2000 Sep; 110(4):813-8. PubMed ID: 11054062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia.
    Lugthart S; Cheok MH; den Boer ML; Yang W; Holleman A; Cheng C; Pui CH; Relling MV; Janka-Schaub GE; Pieters R; Evans WE
    Cancer Cell; 2005 Apr; 7(4):375-86. PubMed ID: 15837626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of in vitro cellular drug resistance on childhood acute lymphoblastic leukemia in Taiwan.
    Chen SH; Yang CP; Jaing TH; Hung IJ; Shih LY; Ho PC; Lee WI; Huang JL
    Leuk Lymphoma; 2012 Aug; 53(8):1536-42. PubMed ID: 22260162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of the apoptotic response to chemotherapy in childhood leukemia.
    Liu T; Raetz E; Moos PJ; Perkins SL; Bruggers CS; Smith F; Carroll WL
    Leukemia; 2002 Feb; 16(2):223-32. PubMed ID: 11840289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukaemia.
    Pieters R; Hongo T; Loonen AH; Huismans DR; Broxterman HJ; Hählen K; Veerman AJ
    Br J Cancer; 1992 May; 65(5):691-7. PubMed ID: 1350207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells.
    Dörrie J; Gerauer H; Wachter Y; Zunino SJ
    Cancer Res; 2001 Jun; 61(12):4731-9. PubMed ID: 11406544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia.
    Pieters R; Kaspers GJ; van Wering ER; Huismans DR; Loonen AH; Hählen K; Veerman AJ
    Leukemia; 1993 Mar; 7(3):392-7. PubMed ID: 8445945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemia.
    Samuels AL; Beesley AH; Yadav BD; Papa RA; Sutton R; Anderson D; Marshall GM; Cole CH; Kees UR; Lock RB
    Blood Cancer J; 2014 Aug; 4(8):e232. PubMed ID: 25083816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells.
    Hulleman E; Kazemier KM; Holleman A; VanderWeele DJ; Rudin CM; Broekhuis MJ; Evans WE; Pieters R; Den Boer ML
    Blood; 2009 Feb; 113(9):2014-21. PubMed ID: 18978206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological and clinical significance of in vitro prednisolone resistance in adult acute lymphoblastic leukaemia.
    Tosi P; Visani G; Ottaviani E; Manfroi S; Tura S
    Eur J Haematol; 1996 Aug; 57(2):134-41. PubMed ID: 8856090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy induces enhanced procoagulant activity through phosphatidylserine exposure in acute lymphoblastic leukemia.
    Dong X; Shi J; Zhou J; Chen X; Jin Y; Zhang X; Li X; Dai H; Wang J
    Thromb Res; 2013 Nov; 132(5):614-20. PubMed ID: 24074703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.